The second-line endocrine therapy landscape in hormone receptor (HR)-positive, HER2-negative advanced breast cancer is ...

Neuroendocrine tumors originate from neuroendocrine cells, often presenting as slower-growing compared to other cancers like ...

Multiple endocrine neoplasia type 2 (MEN2) is a rare hereditary disorder that affects the endocrine glands. Doctors mainly associate MEN2 with tumors of the adrenal gland, the thyroid, and the ...

The endocrine system plays a crucial role in regulating physiological processes and maintaining homeostasis. While previous ...

Numerous companies offer tests, which may involve blood, urine or saliva collection, and can be very expensive. The results ...

Topline data were announced from a phase 3 trial evaluating giredestrant for the adjuvant treatment of estrogen receptor (ER)-positive, human epidermal growth factor receptor 2 (HER2)-negative, ...

Diagnosing an endocrine disorder can be challenging because symptoms often mimic those of other conditions, and treatment plans can be complex. That’s why people with an endocrine disease need to see ...

Endocrine therapy remains a backbone of adjuvant therapy for women with hormone receptor–positive early-stage breast cancer. Numerous studies have demonstrated the benefit of ovarian function ...

Endocrine-disrupting chemicals (EDCs) are a class of chemicals that mimic, block or interfere with the production, metabolism or action of hormones in the body. As EDCs are ubiquitous in our ...

Olema Pharmaceuticals (OLMA) surges after Roche's breast cancer data, but caution is urged as key clinical results are ...